This inventor holds 1 USPTO granted patent. Top assignee: Casebia Therapeutics Limited Liability Partnership. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Andre Cohnen and His Patent in RNA-Programmable Endonuclease Systems.
Introduction
Andre Cohnen is an inventor associated with Cologne, Germany. The available information credits him with 1 patent and lists Casebia Therapeutics Limited Liability Partnership as his company.
Latest Patents
Cohnen is named on the patent titled “Novel High Fidelity RNA-Programmable Endonuclease Systems and Uses Thereof.” The invention concerns RNA-programmable endonuclease systems designed for high-fidelity applications.
Career Highlights
The listed patent connects Cohnen’s work with research into programmable endonucleases, a technology area relevant to genetic engineering and biotechnology. The available details do not specify his role or other career milestones.
Collaborations
Cohnen’s listed coworkers include Moritz Schmidt and Philipp Knyphausen. The provided information does not describe their specific contributions to the patent.
Conclusion
Andre Cohnen’s recorded patent activity centers on a high-fidelity RNA-programmable endonuclease system, reflecting his association with biotechnology innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile